Funding for this research was provided by:
Institute of Nutrition, Metabolism and Diabetes
Heart and Stroke Foundation of Canada
Kidney Foundation of Canada
Received: 8 April 2019
Accepted: 21 August 2019
First Online: 7 November 2019
Duality of interest
: AA has received research support through his institution from Boehringer Ingelheim and AstraZeneca and an unrestricted educational grant from Eli Lilly and has served on advisory boards for Dexcom, Abbott, Eli Lilly/Boehringer Ingelheim and Novo Nordisk.
Free to read: This content has been made available to all.